Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $51.8 million.

  • InspireMD's Net Cash Flow rose 51181.98% to $51.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.4 million, marking a year-over-year increase of 39842.74%. This contributed to the annual value of $9.2 million for FY2024, which is 8209.63% up from last year.
  • Per InspireMD's latest filing, its Net Cash Flow stood at $51.8 million for Q3 2025, which was up 51181.98% from -$874000.0 recorded in Q2 2025.
  • In the past 5 years, InspireMD's Net Cash Flow ranged from a high of $51.8 million in Q3 2025 and a low of -$30.2 million during Q2 2023
  • For the 5-year period, InspireMD's Net Cash Flow averaged around -$239368.4, with its median value being -$1.1 million (2021).
  • Per our database at Business Quant, InspireMD's Net Cash Flow surged by 143402.72% in 2021 and then tumbled by 256558.7% in 2025.
  • Quarter analysis of 5 years shows InspireMD's Net Cash Flow stood at -$1.1 million in 2021, then surged by 165.19% to $691000.0 in 2022, then crashed by 709.7% to -$4.2 million in 2023, then skyrocketed by 172.51% to $3.1 million in 2024, then skyrocketed by 1597.02% to $51.8 million in 2025.
  • Its Net Cash Flow stands at $51.8 million for Q3 2025, versus -$874000.0 for Q2 2025 and -$6.6 million for Q1 2025.